Markets:

Overview

News

Currencies

International

Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

3.085 +0.105 (+3.52%)

Streaming Delayed Price Updated: 1:12 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Agenus Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Agenus (AGEN) Q4 2023 Earnings Call Transcript ↗

March 14, 2024

AGEN earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Agenus Reports Fourth Quarter and Full Year 2023 Results

March 14, 2024

From Agenus Inc.

Via Business Wire

Earnings Scheduled For March 14, 2024 ↗

March 14, 2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

Via Benzinga

Earnings Preview For Agenus ↗

March 13, 2024

Via Benzinga

Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024

March 06, 2024

From Agenus Inc.

Via Business Wire

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 05, 2024

From Agenus Inc.

Via Business Wire

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report

February 29, 2024

From Agenus Inc.

Via Business Wire

Agenus's Earnings Outlook ↗

November 06, 2023

Via Benzinga

Agenus to Participate in Leerink Partners Global Biopharma Conference

February 26, 2024

From Agenus Inc.

Via Business Wire

Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today ↗

February 15, 2024

The company hopes to engineer a 1-for-20 reverse stock split.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 15, 2024

Via Benzinga

7 Analyst-Backed Stocks With Promising 10-Bagger Potential ↗

February 01, 2024

Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot.

Via InvestorPlace

Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference

January 31, 2024

From Agenus Inc.

Via Business Wire

3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024 ↗

January 26, 2024

There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains

Via InvestorPlace

Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population

January 22, 2024

From Agenus Inc.

Via Business Wire

Why LQR House Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket ↗

January 16, 2024

Shares of LQR House Inc. (NASDAQ: LQR) rose sharply in pre-market trading. Borg's investor group has acquired a 20% stake in LQR House. LQR House shares jumped 16.1% to $4.25 in pre-market trading Here...

Via Benzinga

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 05, 2024

From Agenus Inc.

Via Business Wire

Agenus to Participate in B. Riley Healthcare Conference

January 04, 2024

From Agenus Inc.

Via Business Wire

2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street ↗

December 24, 2023

These two biotech stocks could be poised for a trend reversal.

Via The Motley Fool

Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024

December 20, 2023

From Agenus Inc.

Via Business Wire

Agenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific Program

December 11, 2023

From Agenus Inc.

Via Business Wire

Agenus Reports Third Quarter 2023 Results

November 07, 2023

From Agenus Inc.

Via Business Wire

Agenus to Provide Third Quarter 2023 Financial Report and Corporate Update

October 26, 2023

From Agenus Inc.

Via Business Wire

Textainer Group, Roivant Sciences And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

October 23, 2023

U.S. stock futures traded lower this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Agenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma

October 22, 2023

From Agenus Inc.

Via Business Wire

ESMO 2023: Agenus’ Botensilimab/Balstilimab Combination Delivers Durable Responses across Multiple Sarcoma Subtypes

October 21, 2023

From Agenus Inc.

Via Business Wire

Agenus Completes Enrollment in Randomized Phase 2 Clinical Trial of Botensilimab/Balstilimab in Advanced Colorectal Cancer

October 10, 2023

From Agenus Inc.

Via Business Wire

Agenus To Host BOT/BAL Program Update at ESMO 2023

October 05, 2023

From Agenus Inc.

Via Business Wire

Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 01, 2023

From Agenus Inc.

Via Business Wire

HEICO, Canaan And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 29, 2023

U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session. HEICO Corporation (NYSE: HEI) shares tumbled 5.3% to $159.01...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.